Lin, D.-Yin
Brown, Brigid
Morrison, Craig
Fraser, Nikolai S.
Chooi, Cheryl S. L.
Cehic, Matthew G.
McLeod, David H.
Henningsen, Michael D.
Sladojevic, Nikolina
Kroon, Hidde M.
Jaarsma, Ruurd L.
Article History
Received: 27 May 2022
Accepted: 25 July 2022
First Online: 6 August 2022
Declarations
:
: This multi-centre double-blinded randomized-controlled trial was conducted at two teaching hospitals in Adelaide, Australia; Noarlunga Health Services (NHS) and Flinders Medical Centre (FMC). Institutional ethics approval was obtained (SALHN/HREC/292.20) and written informed consent was acquired from all participants.All methods were carried out in accordance with relevant guidelines and regulations.
: All participants gave written informed consent to participation and also to publication. Ethical approval also includes publication of results in a deidentified manner.
: The authors declare no competing interests.